Safety of an Accelerated Ferric Gluconate Inpatient Infusion Regimen
In this retrospective single-center study of hospitalized adult patients, those who received intravenous ferric gluconate twice daily did not experience an increased rate of a composite safety outcome of hypotension, infusion reactions, or escalation in level of care compared with those with daily dosing.
Authors
- Lauren McCluggage (ORCID: https://orcid.org/0009-0004-0387-9310)
- Edythe A. Gray (ORCID: https://orcid.org/0009-0002-5543-0959)
- Tate D. Parrott
Institutions
- Augusta University (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- Journal of Pharmacy Technology
- Published
- 2024-10-27
- DOI
- https://doi.org/10.1177/87551225241288144
- Primary Topic
- Iron Metabolism and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00